NCT04056416

Brief Summary

Single ventricular (SV) heart was a uniformly fatal condition before the advances in surgical treatment in 1980. In the present era, 5-year survival rate with SV is 75%, with some centers, including the Stollery Children's Hospital reporting higher survival. Although mortality remains a major concern, the research focus has shifted to management of late complications as well as improving patient physical and mental health related quality of life issues. Children with SV have reduced exercise tolerance and this is progressive through adulthood. Recent advances in remote health assessment and telehealth systems have allowed the development of medically supervised home graduated physical training for adult cardiac patient rehabilitation. To our knowledge, the application of these technologies has not been applied to SV patients. The long term goal is to use this technology to improve patient exercise capacity and to positively influence parental and patient perceptions of the patient's physical ability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 25, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2020

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2022

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

12 months

First QC Date

April 25, 2019

Last Update Submit

November 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Exercise capacity

    Exercise capacity assessed as the change in max VO2 pre- vs. post- completion of the HIIT exercise program. Hypothesis- we will observe an increased in VO2 max of 15%.

    Pre- VO2 max performed 1 week before 24 HIIT exercise sessions and within 1 week after last session

Secondary Outcomes (2)

  • Qualitative interviews to determine the perception of exercise in CHD patient

    Pre-interview conducted within 2 weeks of beginning 24 HIIT exercise sessions and post interview conducted within 2 weeks after last session

  • Number of participants with exercise program specific adverse events

    Data on acute events are recorded only during the study regiment (24 HIIT sessions); 8 weeks total

Study Arms (1)

HIIT Exercise Program

EXPERIMENTAL

Exercise on a MedBIKE 3 times a week for 8 weeks with pre- and post-CPET testing, questionnaires and qualitative interviews.

Device: MedBIKE

Interventions

MedBIKEDEVICE

A MedBIKE will be installed into a participants home and connected to clinicians via telehealth for monitoring during exercise sessions. Sessions will be based on standardized guidelines for aerobic exercise. Heart rate, ECG, oxygen saturation and rating of perceived exertion will be monitored throughout the session.

HIIT Exercise Program

Eligibility Criteria

Age10 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • single ventricle patients with Fontan circulation

You may not qualify if:

  • Cardiac arrhythmias
  • Persistent low resting oxygen saturation of \< 85%
  • Severe ventricular dysfunction on most recent clinical echocardiogram
  • Patients with reports of chest pain on exertion
  • Restricted exercise by cardiologist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G 2B7, Canada

Location

MeSH Terms

Conditions

Heart Defects, CongenitalHypoplastic Left Heart SyndromeMotor Activity

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Study Officials

  • Nee Khoo, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2019

First Posted

August 14, 2019

Study Start

March 25, 2019

Primary Completion

March 19, 2020

Study Completion

November 9, 2022

Last Updated

November 30, 2022

Record last verified: 2022-11

Locations